Clinical Trials · NCT01515553
Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 22
- Start date
- Jan 2007
- Locations
- 1 site, Sweden
- Primary endpoint
- Area under the curve (0-t)